Sae-bom Jeon

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity.

Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity.

Journal: Antioxidants (Basel, Switzerland)

Published: November 15, 2025

MicroRNA-1912 regulates cholesterol homeostasis by targeting PCSK9.

MicroRNA-1912 regulates cholesterol homeostasis by targeting PCSK9.

Journal: Molecular therapy. Nucleic acids

Published: December 17, 2024

Hydroethanolic extract of Cirsium setidens ameliorates doxorubicin-induced cardiotoxicity by AMPK-PGC-1α-SOD-mediated mitochondrial protection.

Hydroethanolic extract of Cirsium setidens ameliorates doxorubicin-induced cardiotoxicity by AMPK-PGC-1α-SOD-mediated mitochondrial protection.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 16, 2023

Human induced pluripotent stem cell line YCMi007-A generated from a dilated cardiomyopathy patient with a heterozygous dominant c.613C > T (p. Arg205Trp) variant of the TNNT2 gene.

Human induced pluripotent stem cell line YCMi007-A generated from a dilated cardiomyopathy patient with a heterozygous dominant c.613C > T (p. Arg205Trp) variant of the TNNT2 gene.

Journal: Stem cell research

Published: November 21, 2022

Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis.

Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis.

Journal: Experimental & molecular medicine

Published: July 07, 2022

Derivation of YCMi005-A, a human-induced pluripotent stem cell line, from a patient with dilated cardiomyopathy carrying missense variant in TPM1 (p. Glu192Lys).

Derivation of YCMi005-A, a human-induced pluripotent stem cell line, from a patient with dilated cardiomyopathy carrying missense variant in TPM1 (p. Glu192Lys).

Journal: Stem cell research

Published: December 15, 2021

Glial TLR2-driven innate immune responses and CD8+ T cell activation against brain tumor.

Glial TLR2-driven innate immune responses and CD8+ T cell activation against brain tumor.

Journal: Glia

Published: May 08, 2018

Glatiramer acetate attenuates the activation of CD4+ T cells by modulating STAT1 and -3 signaling in glia.

Glatiramer acetate attenuates the activation of CD4+ T cells by modulating STAT1 and -3 signaling in glia.

Journal: Scientific reports

Published: August 22, 2016

Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation.

Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation.

Journal: Brain research bulletin

Published: November 06, 2014

EOP, a newly synthesized ethyl pyruvate derivative, attenuates the production of inflammatory mediators via p38, ERK and NF-κB pathways in lipopolysaccharide-activated BV-2 microglial cells.

EOP, a newly synthesized ethyl pyruvate derivative, attenuates the production of inflammatory mediators via p38, ERK and NF-κB pathways in lipopolysaccharide-activated BV-2 microglial cells.

Journal: Molecules (Basel, Switzerland)

Published: October 10, 2014

Distinctive responses of brain tumor cells to TLR2 ligands.

Distinctive responses of brain tumor cells to TLR2 ligands.

Journal: Glia

Published: April 10, 2014

Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathways.

Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathways.

Journal: PloS one

Published: October 04, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026